Matches in Wikidata for { <http://www.wikidata.org/entity/Q45204128> ?p ?o ?g. }
- Q45204128 description "2004 nî lūn-bûn" @default.
- Q45204128 description "2004年の論文" @default.
- Q45204128 description "2004年学术文章" @default.
- Q45204128 description "2004年学术文章" @default.
- Q45204128 description "2004年学术文章" @default.
- Q45204128 description "2004年学术文章" @default.
- Q45204128 description "2004年学术文章" @default.
- Q45204128 description "2004年学术文章" @default.
- Q45204128 description "2004年學術文章" @default.
- Q45204128 description "2004年學術文章" @default.
- Q45204128 description "2004年學術文章" @default.
- Q45204128 description "2004年學術文章" @default.
- Q45204128 description "2004年學術文章" @default.
- Q45204128 description "2004년 논문" @default.
- Q45204128 description "article científic" @default.
- Q45204128 description "article scientific" @default.
- Q45204128 description "article scientifique" @default.
- Q45204128 description "articol științific" @default.
- Q45204128 description "articolo scientifico" @default.
- Q45204128 description "artigo científico" @default.
- Q45204128 description "artigo científico" @default.
- Q45204128 description "artigo científico" @default.
- Q45204128 description "artikel ilmiah" @default.
- Q45204128 description "artikull shkencor" @default.
- Q45204128 description "artikulong pang-agham" @default.
- Q45204128 description "artykuł naukowy" @default.
- Q45204128 description "artículo científico publicado en 2004" @default.
- Q45204128 description "artículu científicu" @default.
- Q45204128 description "bilimsel makale" @default.
- Q45204128 description "bài báo khoa học" @default.
- Q45204128 description "naučni članak" @default.
- Q45204128 description "scienca artikolo" @default.
- Q45204128 description "scientific article published in December 2004" @default.
- Q45204128 description "scientific article published in December 2004" @default.
- Q45204128 description "scientific article published in December 2004" @default.
- Q45204128 description "teaduslik artikkel" @default.
- Q45204128 description "tieteellinen artikkeli" @default.
- Q45204128 description "tudományos cikk" @default.
- Q45204128 description "vedecký článok" @default.
- Q45204128 description "vetenskaplig artikel" @default.
- Q45204128 description "videnskabelig artikel" @default.
- Q45204128 description "vitenskapelig artikkel" @default.
- Q45204128 description "vitskapeleg artikkel" @default.
- Q45204128 description "vědecký článek" @default.
- Q45204128 description "wetenschappelijk artikel" @default.
- Q45204128 description "wissenschaftlicher Artikel" @default.
- Q45204128 description "επιστημονικό άρθρο" @default.
- Q45204128 description "мақолаи илмӣ" @default.
- Q45204128 description "наукова стаття, опублікована в грудні 2004" @default.
- Q45204128 description "научна статия" @default.
- Q45204128 description "научная статья" @default.
- Q45204128 description "научни чланак" @default.
- Q45204128 description "научни чланак" @default.
- Q45204128 description "מאמר מדעי" @default.
- Q45204128 description "مقالة علمية نشرت في ديسمبر 2004" @default.
- Q45204128 description "ডিসেম্বর ২০০৪-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q45204128 description "บทความทางวิทยาศาสตร์" @default.
- Q45204128 description "სამეცნიერო სტატია" @default.
- Q45204128 name "Bendamustine/Mitoxantrone/Rituximab (BMR): a very effective, well tolerated outpatient chemoimmunotherapy for relapsed and refractory CD20-positive indolent malignancies. Final results of a pilot study" @default.
- Q45204128 name "Bendamustine/Mitoxantrone/Rituximab (BMR): a very effective, well tolerated outpatient chemoimmunotherapy for relapsed and refractory CD20-positive indolent malignancies. Final results of a pilot study" @default.
- Q45204128 type Item @default.
- Q45204128 label "Bendamustine/Mitoxantrone/Rituximab (BMR): a very effective, well tolerated outpatient chemoimmunotherapy for relapsed and refractory CD20-positive indolent malignancies. Final results of a pilot study" @default.
- Q45204128 label "Bendamustine/Mitoxantrone/Rituximab (BMR): a very effective, well tolerated outpatient chemoimmunotherapy for relapsed and refractory CD20-positive indolent malignancies. Final results of a pilot study" @default.
- Q45204128 prefLabel "Bendamustine/Mitoxantrone/Rituximab (BMR): a very effective, well tolerated outpatient chemoimmunotherapy for relapsed and refractory CD20-positive indolent malignancies. Final results of a pilot study" @default.
- Q45204128 prefLabel "Bendamustine/Mitoxantrone/Rituximab (BMR): a very effective, well tolerated outpatient chemoimmunotherapy for relapsed and refractory CD20-positive indolent malignancies. Final results of a pilot study" @default.
- Q45204128 P1433 Q45204128-CADF2AF3-4B50-4EA6-9988-83AC0C928F26 @default.
- Q45204128 P1476 Q45204128-86C44602-B2B4-4120-B8F8-A09E24425B08 @default.
- Q45204128 P2093 Q45204128-4886BA84-918C-47F4-B19F-6994BFF39697 @default.
- Q45204128 P2093 Q45204128-86AB95EA-0D61-4675-95FE-5C00D51186D4 @default.
- Q45204128 P2093 Q45204128-90C459DF-1F4B-42AC-BE81-F87EC84142F6 @default.
- Q45204128 P2093 Q45204128-F386F94E-92B2-4630-952E-B24D60C73DBA @default.
- Q45204128 P2860 Q45204128-BC6A2EBB-667A-47D7-A0D3-6728DBFDE49C @default.
- Q45204128 P2860 Q45204128-CD1257EE-A2FD-4A3B-BC44-BF0A370684D7 @default.
- Q45204128 P2860 Q45204128-E7D170E8-141E-4ECD-A91B-3E1268772B72 @default.
- Q45204128 P2860 Q45204128-EA8EBAFC-847B-429C-A752-2790C800369A @default.
- Q45204128 P2860 Q45204128-FFE5C8E5-773F-47E7-A430-F9E6CD38EEB6 @default.
- Q45204128 P304 Q45204128-C90D16BF-0B71-4947-9DE1-D4EA73627913 @default.
- Q45204128 P31 Q45204128-EEC4107C-441D-4628-B204-645FA2CCB46E @default.
- Q45204128 P356 Q45204128-F8F85D80-5548-4138-B2EF-6C1F580D902D @default.
- Q45204128 P433 Q45204128-000B358C-9750-4B00-9154-16DBD9A8A958 @default.
- Q45204128 P478 Q45204128-EF829694-1D0F-41BB-985D-E38EAFE2CDBF @default.
- Q45204128 P577 Q45204128-E6F4AA0C-3FD0-4927-B5F3-CFEDFE14D413 @default.
- Q45204128 P698 Q45204128-DA8FBB34-ED2C-44AB-8319-528B69ED5527 @default.
- Q45204128 P356 10428190400004521 @default.
- Q45204128 P698 15621757 @default.
- Q45204128 P1433 Q6534493 @default.
- Q45204128 P1476 "Bendamustine/Mitoxantrone/Rituximab (BMR): a very effective, well tolerated outpatient chemoimmunotherapy for relapsed and refractory CD20-positive indolent malignancies. Final results of a pilot study" @default.
- Q45204128 P2093 "Annette Pandorf" @default.
- Q45204128 P2093 "Hubert Köppler" @default.
- Q45204128 P2093 "Jochen Heymanns" @default.
- Q45204128 P2093 "Rudolf Weide" @default.
- Q45204128 P2860 Q33773306 @default.
- Q45204128 P2860 Q34662857 @default.
- Q45204128 P2860 Q40634072 @default.
- Q45204128 P2860 Q41262857 @default.
- Q45204128 P2860 Q43985638 @default.
- Q45204128 P304 "2445-2449" @default.
- Q45204128 P31 Q13442814 @default.
- Q45204128 P356 "10.1080/10428190400004521" @default.
- Q45204128 P433 "12" @default.